adalimumab

Friday Pop Quiz 9/6/2024
A 35-year-old woman presents to clinic with the skin lesions (shown) and joint pain. She was previously well controlled on guselkumab, but has flared since her dog was diagnosed with cancer. She has previously failed various treatments including topical steroids, methotrexate, narrow-band UVB, adalimumab, ixekizumab, and etanercept. She developed transaminitis and hepatic steatosis in response t …
Improvement of Pretibial Myxedema Following Administration of Teprotumumab
Pretibial MyxedemaPretibial myxedema (PTM) is a rare complication of Graves' disease. It is characterized by non-pitting edema with hyperpigmented hyperkeratotic papules and plaques on bilateral lower legs. Effective treatments for patients with PTM are lacking. The etiology of PTM is unknown; however, it may be similar to the mechanism of thyroid-associated ophthalmopathy (TAO). Activated fibroblasts produce infla …
Pretibial Myxedema
Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab
Dissecting CellulitisPerifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular lesions with purulent drainage and sinus tract formation. It is classically seen in middle-aged males of African descent. The etiology of the disease is unknown; however, leading theories …
Dissecting Cellulitis
JDD June 2023 Issue Highlights
acneThe June issue of the Journal of Drugs in Dermatology (JDD) features original articles with topics ranging from pediatric acne, rosacea, androgenetic alopecia, precision medicine, infantile hemangiomas, and many more.  Check out this month’s issue highlights straight from the JDD Editor’s desk: The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and …
acne
Pediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient
Pediatric Verrucous PsoriasisVerrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options are limited, and the disease is often refractory to conventional methods. Herein, JDD authors Samantha Sherkin OMS-IV, Christian Summa OMS-IV, David Crasto DO, Zackary Whitney DO, Lazlo Karai MD PhD,� …
Pediatric Verrucous Psoriasis